Suscribirse

P48: Death by 4-methylethcathinone (4-MEC) overdose: A case report - 28/06/14

Doi : 10.1016/S2352-0078(14)70109-X 
C. Bottinelli 1, F. Bevalot 1, A. Boucher 2, C. Le Meur 1, L. Fanton 3
1 Lat Lumtox, Lyon, France 
2 CEIP-Addictovigilance, CHU Lyon, Lyon, France 
3 Service de médecine légale, CHU Lyon, Lyon, France 

Resumen

Objective

4-methylethcathinone (4-MEC) is a designer cathinone classified as an illegal narcotic since July 2012 in France. This report presents the first fatality related to consumption of 4-MEC in France.

Case description

A 36 year-old man, in psychotherapy for drug addiction and suicide attempts, was found dead in his apartment. Three empty syringes were found near the corpse. His boyfriend told the police that the deceased was an intravenous user of drugs purchased on the Internet. No obvious cause of death was identified at autopsy. Several marks from needle and a rectal foreign body were observed. Blood, urine, vitreous humor, bile, gastric contents and hair samples were collected.

Methods

Immunological screening for amphetamine, methamphetamine, opiates, cannabinoids, cocaine, buprenorphine and MDMA was performed on urine. Identification and quantification of major amphetamine derivatives (amphetamine, methamphetamine, MDMA, MDA, MDEA and MBDB) was performed on urine and blood, following the SFTA GC-MS consensus protocol. General unknown screening (GUS) was performed on peripheral blood and gastric contents by GC-MS (spectral libraries: Nist11, Pfleger2011, Wiley, SWDrug) and on central blood by LC/DAD after liquid-liquid extraction. 4-MEC was quantified in blood by GC-MS/MS, using mephedrone-d3 as internal standard. The assay was validated for linearity, selectivity, limits of detection, precision and accuracy at 3 concentration levels. Analysis of ethanol and other volatile compounds was performed using headspace gas chromatography coupled to flame ionization detector.

Results

Immunological screening was positive for amphetamine, methamphetamine and MDMA. Confirmation analysis for major amphetamine derivatives was negative. Hydroxyzine was quantified at therapeutic concentration (160ng/ml) in blood. 4-MEC was detected on GUS by GC-MS using the SWDrug mass spectra library. The concentration of 4-MEC was 14,600ng/mL in peripheral blood. Quantification in other matrices is ongoing. No other drugs/toxins were found, and screening for ethanol was negative. Analysis of syringes, performed in a different laboratory, detected 4-MEC.

Conclusion

Reports of use of 4-MEC have mainly described nonfatal intoxications, with blood concentrations about 100-fold lower than in the present case; only one fatal case has been reported in the literature (Rojek S., Meeting of IAFT, Japan, 2012), in which 4-MEC blood concentration was 1,267ng/ml. In the present case, the circumstances of death, autopsy findings and toxicology results, with a 4-MEC concentration of 14,600ng/ml, were consistent with 4-MEC overdose as cause of death.

El texto completo de este artículo está disponible en PDF.

© 2014  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 26 - N° 2S

P. S50 - juin 2014 Regresar al número
Artículo precedente Artículo precedente
  • P47: Methemoglobinemia following Dapsone poisoning (DDS)
  • A. El AttarI, S. Achour, I. Iken, M. Meziane, B. El Youssi, A. Amarti, F.Z. Mernissi
| Artículo siguiente Artículo siguiente
  • P49: Collective poisoning by Atractylis gummifera L., Morocco
  • S. Achour, A. Berdai, I. Iken, A. Attari, A. Amarti, M. Harandou

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.